BNP Paribas Financial Markets Sells 101,576 Shares of Revvity Inc. $RVTY

BNP Paribas Financial Markets reduced its stake in shares of Revvity Inc. (NYSE:RVTY) by 49.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 103,421 shares of the company’s stock after selling 101,576 shares during the quarter. BNP Paribas Financial Markets’ holdings in Revvity were worth $10,006,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of RVTY. CYBER HORNET ETFs LLC acquired a new position in Revvity in the second quarter valued at approximately $32,000. Cromwell Holdings LLC lifted its holdings in Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after buying an additional 198 shares during the period. MUFG Securities EMEA plc acquired a new position in Revvity in the second quarter valued at approximately $34,000. Headlands Technologies LLC acquired a new position in Revvity in the second quarter valued at approximately $49,000. Finally, Smartleaf Asset Management LLC lifted its holdings in Revvity by 56.8% in the third quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock valued at $58,000 after buying an additional 250 shares during the period. 86.65% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

RVTY has been the topic of several analyst reports. JPMorgan Chase & Co. cut their target price on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Weiss Ratings lowered shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 13th. Wolfe Research began coverage on shares of Revvity in a report on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Barclays increased their price objective on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Finally, Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Four investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $107.73.

Revvity Stock Up 2.1%

Revvity stock opened at $100.46 on Tuesday. The company has a market cap of $11.21 billion, a P/E ratio of 48.07, a price-to-earnings-growth ratio of 2.15 and a beta of 1.11. Revvity Inc. has a 1-year low of $81.22 and a 1-year high of $118.30. The company has a fifty day simple moving average of $93.67 and a 200 day simple moving average of $97.58. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last released its earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Research analysts anticipate that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio (DPR) is 13.40%.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.